In a mouse model of ischemia/reperfusion kidney injury, serum and urine KIM-1 levels increased during the acute phase and declined gradually in the chronic phase, while serum and urine NGAL levels increased continuously during the transition from AKI to chronic kidney disease, which suggests that NGAL is a valuable biomarker in this setting [41]. This evidence concerns the gene LCN2 and chronic kidney disease.